Acromegaly Market Insights, Epidemiology and Market Forecasts, 2016-2018 & 2027 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Acromegaly - Market Insights, Epidemiology and Market Forecast-2027” drug pipelines has been added to ResearchAndMarkets.com’s offering.
Acromegaly - Market Insights, Epidemiology and Market Forecast-2027′ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Acromegaly in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Acromegaly from 2016 to 2027 segmented by seven major markets. The Report also covers the current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
The Acromegaly epidemiology division provides the insights about historical and current patient pool and forecasted trend for 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Topics Covered:
1. Key Insights
2. Acromegaly Market Overview at a Glance
3. Disease Overview: Acromegaly (ACM)
4. Epidemiology and Patient Population
5. Key Findings
6. 7MM Epidemiology
7. United States Epidemiology
8. EU5 Epidemiology
9. Japan Epidemiology
11. Unmet Needs
12. Marketed Drug
13. Key Cross Competitors
14. Emerging Drugs
15. Acromegaly: 7 Major Market Analysis
16. The United States: Market Outlook
17. EU5: Market Outlook
18. Japan: Market Outlook
19. Market Drivers
20. Market Barriers
Companies MentionedIpsen Pharmaceuticals Pharmacia & Upjohn Novartis Ionis Pharmaceuticals Antisense Therapeutics Pharmaspur Aspireo Pharmaceuticals
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hldbwm/acromegaly_market?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005813/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Endocrine and Metabolic Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 02:37 PM/DISC: 09/27/2018 02:36 PM